Recherche - Université de Limoges Accéder directement au contenu

Filtrer vos résultats

26 Résultats
Auteur : personID (entier) : 862464
Image document

Effect of CYP3A4*22, POR*28, and PPARA rs4253728 on sirolimus in vitro metabolism and trough concentrations in kidney transplant recipients.

Jean-Baptiste Woillard , Nassim Kamar , Sandra Coste , Lionel Rostaing , Pierre Marquet , et al.
Clinical Chemistry, 2013, 59 (12), pp.1761-9. ⟨10.1373/clinchem.2013.204990⟩
Article dans une revue inserm-00852753v1
Image document

Association of sirolimus adverse effects with m-TOR, p70S6K or Raptor polymorphisms in kidney transplant recipients.

Jean-Baptiste Woillard , Nassim Kamar , Annick Rousseau , Lionel Rostaing , Pierre Marquet , et al.
Pharmacogenet Genomics, 2012, 22 (10), pp.725-32. ⟨10.1097/FPC.0b013e328357359d⟩
Article dans une revue inserm-00724758v1

Renal transplantation in patients with AA amyloidosis nephropathy: results from a French multicenter study.

T. Kofman , P. Grimbert , F. Canouï-Poitrine , J. Zuber , V. Garrigue , et al.
American Journal of Transplantation, 2011, 11 (11), pp.2423-31. ⟨10.1111/j.1600-6143.2011.03620.x⟩
Article dans une revue hal-00945699v1

Inhibition of T-cell activation and proliferation by mycophenolic acid in patients awaiting liver transplantation: PK/PD relationships.

Aurélie Prémaud , Annick Rousseau , Gyasi Johnson , Cindy Canivet , Peggy Gandia , et al.
Pharmacological Research, 2011, 63 (5), pp.432-8. ⟨10.1016/j.phrs.2011.01.005⟩
Article dans une revue istex inserm-00926481v1

Early steroid withdrawal and optimization of mycophenolic acid exposure in kidney transplant recipients receiving mycophenolate mofetil.

Yannick Le Meur , Antoine Thierry , François Glowacki , Jean-Philippe Rerolle , Valerie Garrigue , et al.
Transplantation, 2011, 92 (11), pp.1244-51. ⟨10.1097/TP.0b013e318234e134⟩
Article dans une revue hal-01151208v1
Image document

Ciclosporin population pharmacokinetics and Bayesian estimation in thoracic transplant recipients

Dorothée Fruit , Annick Rousseau , Catherine Amrein , Florence Rollé , Nassim Kamar , et al.
Pré-publication, Document de travail inserm-00764040v1
Image document

Clinical utility of biochemical markers for the prediction of COVID-19-related mortality in kidney transplant recipients

Sophie Caillard , Nathalie Chavarot , Helene Francois , Marie Matignon , Renaud Snanoudj , et al.
Kidney International Reports, 2021, 6 (10), pp.2689-2693. ⟨10.1016/j.ekir.2021.06.034⟩
Article dans une revue hal-03333553v2

Development and evaluation of a simulation procedure to take into account various assays for the Bayesian dose adjustment of tacrolimus.

Franck Saint-Marcoux , Jean Debord , François Parant , Myriam Labalette , Nassim Kamar , et al.
Therapeutic Drug Monitoring, 2011, 33 (2), pp.171-7. ⟨10.1097/FTD.0b013e31820d6ef7⟩
Article dans une revue inserm-00926394v1
Image document

Impact of previous exposure to systemic corticosteroids on unfavorable outcome in patients hospitalized for COVID-19

Margaux Lafaurie , Guillaume Martin-Blondel , Pierre Delobel , Nassim Kamar , Sandrine Charpentier , et al.
BMC Pharmacology and Toxicology, 2021, 22, pp.14. ⟨10.1186/s40360-021-00480-3⟩
Article dans une revue hal-03683634v1

Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence - The ANRS CUPILT study

Audrey Coilly , Claire Fougerou-Leurent , Victor De Ledinghen , Pauline Houssel-Debry , Christophe Duvoux , et al.
Journal of Hepatology, 2016, 65 (4), pp.711--718. ⟨10.1016/j.jhep.2016.05.039⟩
Article dans une revue hal-01395132v1
Image document

Direct-acting antiviral agent-based regimen for HCV recurrence after combined liver-kidney transplantation: Results from the ANRS CO23 CUPILT study

Sébastien Dharancy , Audrey Coilly , Claire Fougerou-Leurent , Christophe Duvoux , Nassim Kamar , et al.
American Journal of Transplantation, 2017, 17 (11), pp.2869-2878. ⟨10.1111/ajt.14490⟩
Article dans une revue hal-01640061v1
Image document

Adherence profiles in kidney transplant patients: Causes and consequences

Claire Villeneuve , Annick Rousseau , Jean-Phillipe Rerolle , Lionel Couzi , Nassim Kamar , et al.
Patient Education and Counseling, 2020, 103 (1), pp.189 - 198. ⟨10.1016/j.pec.2019.08.002⟩
Article dans une revue hal-03488791v1

Monitoring human cytomegalovirus (HCMV) in HCMV-seropositive orthotopic liver-transplant recipients by means of quantitative real-time polymerase chain reaction

Catherine Mengelle , Florence Legrand-Abravanel , Nassim Kamar , Sophie Alain , Grégoire Basse , et al.
Exp Clin Transplant, 2006, 4 (2), pp.537-543
Article dans une revue hal-00406614v1
Image document

Combined Liver-Kidney Transplantation With Preformed Anti–human Leukocyte Antigen Donor-Specific Antibodies

Arnaud del Bello , Olivier Thaunat , Moglie Le Quintrec , Oriol Bestard , Antoine Durrbach , et al.
Kidney International Reports, 2020, ⟨10.1016/j.ekir.2020.09.018⟩
Article dans une revue hal-03185936v1


Julien Zuber , Nassim Kamar , Marie Frimat , Moglie Le Quintrec , Philippe Gatault , et al.
European Society for Organ Transplantation Congress 2017, Sep 2017, BARCELONE, Spain
Communication dans un congrès hal-01787228v1

Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome.

M. Le Quintrec , J. Zuber , B. Moulin , Nassim Kamar , M. Jablonski , et al.
American Journal of Transplantation, 2013, 13 (3), pp.663-75. ⟨10.1111/ajt.12077⟩
Article dans une revue hal-00945715v1
Image document

CYP3A5 genotype does not influence everolimus in vitro metabolism and clinical pharmacokinetics in renal transplant recipients.

Nicolas Picard , Koukeb Rouguieg-Malki , Nassim Kamar , Lionel Rostaing , Pierre Marquet
Transplantation, 2011, 91 (6), pp.652-6. ⟨10.1097/TP.0b013e31820ae4ac⟩
Article dans une revue inserm-00542366v1

Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in renal transplant recipients on a new once-daily formulation.

Khaled Benkali , Lionel Rostaing , Aurélie Prémaud , Jean-Baptiste Woillard , Franck Saint-Marcoux , et al.
Clinical Pharmacokinetics, 2010, 49 (10), pp.683-92. ⟨10.2165/11535950-000000000-00000⟩
Article dans une revue inserm-00926496v1
Image document

Risk factors of de novo malignancies after liver transplantation: a French national study on 11004 adult patients

Mario Altieri , Olivier Sérée , Thierry Lobbedez , Philippe Segol , Armand Abergel , et al.
Clinics and Research in Hepatology and Gastroenterology, 2021, 45 (4), pp.101514. ⟨10.1016/j.clinre.2020.07.019⟩
Article dans une revue hal-03671648v1

Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study

Nassim Kamar , Elisabeth Cassuto , Giovanni Piotti , Mirco Govoni , Giorgia Ciurlia , et al.
Advances in Therapy, 2019, 36 (2), pp.462-477. ⟨10.1007/s12325-018-0855-1⟩
Article dans une revue hal-02265179v1
Image document

Population pharmacokinetic model and Bayesian estimator for two tacrolimus formulations - twice daily Prograf(®) and once daily Advagraf(®).

Jean-Baptiste Woillard , Brenda C.M. de Winter , Nassim Kamar , Pierre Marquet , Lionel Rostaing , et al.
British Journal of Clinical Pharmacology, 2011, 71 (3), pp.391-402. ⟨10.1111/j.1365-2125.2010.03837.x⟩
Article dans une revue inserm-00544205v1

Evolution and Determinants of Health-Related Quality-of-Life in Kidney Transplant Patients Over the First 3 Years After Transplantation.

Claire Villeneuve , Marie-Laure Laroche , Marie Essig , Pierre Merville , Nassim Kamar , et al.
Transplantation, 2016, 100 (3), pp.640-7
Article dans une revue hal-01285231v1

Conversion from everolimus with low-exposure cyclosporine to everolimus with mycophenolate sodium maintenance therapy in kidney transplant recipients: a randomized, open-label multicenter study.

Laetitia Albano , Eric Alamartine , Olivier Toupance , Bruno Moulin , Pierre Merville , et al.
Annals of Transplantation, 2014, 17 (1), pp.58-67
Article dans une revue inserm-00925721v1

Sofosbuvir and NS5A inhibitors without Ribavirin during 12 weeks are efficient to treat hepatitis C recurrence after liver transplantation only in genotype 1. Results from the CO23 ANRS CUPILT study.

Pauline Houssel-Debry , Audrey Coilly , Claire Fougerou-Leurent , Caroline Jezequel , Christophe Duvoux , et al.
Hepatology, 2017, 63 (1 SUPP), pp.465A--465A
Article dans une revue hal-01412958v1

Longterm Risk of Solid Organ De Novo Malignancies After Liver Transplantation: A French National Study on 11,226 Patients

Olivier Sérée , Mario Altieri , Elodie Guillaume , Rémy de Mil , Thierry Lobbedez , et al.
Liver Transplantation, 2018, 24 (10), pp.1425-1436. ⟨10.1002/lt.25310⟩
Article dans une revue hal-02000599v1

Nonskeletal and skeletal effects of high doses versus low doses of vitamin D3 in renal transplant recipients: Results of the VITALE (VITamin D supplementation in renAL transplant recipients) study, a randomized clinical trial

Marie Courbebaisse , Aurelie Bourmaud , Jean-Claude Souberbielle , Rebecca Sberro-Soussan , Valérie Moal , et al.
American Journal of Transplantation, 2023, 23 (3), pp.366-376. ⟨10.1016/j.ajt.2022.12.007⟩
Article dans une revue hal-04179884v1